Daryl Edward Kurz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1951 Evelyn Byrd Ave, Suite I, Harrisonburg, VA 22801 Phone: 540-437-5879 |
Dr. David Pan, M.D. Ophthalmology - Retina Specialist Medicare: Medicare Enrolled Practice Location: 1880 Reservoir St Ste A, Harrisonburg, VA 22801 Phone: 540-920-2020 Fax: 540-920-0828 |
Dr. Kenlyn Shawn Miller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1921 Medical Ave, Harrisonburg, VA 22801 Phone: 540-433-2485 Fax: 540-433-2010 |
Dr. Paul Roy Yoder Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1921 Medical Ave, Harrisonburg, VA 22801 Phone: 540-433-2485 Fax: 540-433-2010 |
Dr. Richard Andrew Seefried, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1921 Medical Ave, Harrisonburg, VA 22801 Phone: 540-433-2485 Fax: 540-433-2010 |
Robert S Mccormick, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3344 Emmaus Road, Harrisonburg, VA 22801 Phone: 540-434-5668 Fax: 540-434-5795 |
Dr. Ronald Edward Capstack, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1921 Medical Ave, Harrisonburg, VA 22801 Phone: 540-433-2485 Fax: 540-433-2010 |
Dr. Christopher James Eller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1921 Medical Ave, Harrisonburg, VA 22801 Phone: 540-433-2485 |
News Archive
Patients in England could be some of the first in the world to be treated with revolutionary cancer drugs that can target any type of tumor.
Today's headlines include reports about two new studies exploring whether the slowdown in the nation's health spending growth rates is, in fact, due more to structural changes in the health ystem than to the economy.
A dramatic new study published in the most recent issue of Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.
Invasive lobular carcinoma (ILC) of the breast can be treated with breast conserving surgery (BCT), as is invasive ductal carcinoma (IDC), without greater future risk of radical surgical treatment or additional surgeries, according to a new study.
Two teams of researchers at UC San Diego and other U.S. and African universities and the World Bank have documented significant spillover benefits of a drug therapy to combat AIDS symptoms and a novel prevention strategy that focuses on girls in Sub-Saharan Africa, an area with two-thirds of the world's HIV infections.
› Verified 5 days ago